The WCN 2025 Bombay blood group transplant abstract marked a historic moment in renal science. I am proud to share that at the World Congress of Nephrology (WCN) 2025 in New Delhi, our team at MIOT Hospitals first announced a massive leap forward in transplant immunology.
Details of the WCN 2025 Bombay Blood Group Transplant
The abstract, titled “A QUANTUM LEAP IN RENAL SCIENCE: THE FIRST EVER ABH INCOMPATIBLE RENAL TRANSPLANT IN A RECIPIENT WITH BOMBAY BLOOD PHENOTYPE,” was presented to the global nephrology community. As the senior and lead author, I had the privilege of leading the team that made this achievement possible.
This conference presentation detailed the world’s first successful kidney transplant in a patient with the Bombay blood phenotype—a condition previously considered an absolute contraindication for transplantation due to the presence of potent anti-H antibodies.
Following this presentation, the full clinical details of the case were peer-reviewed and published in the American Journal of Transplantation.
Read the full peer-reviewed paper published in the American Journal of Transplantation
Dr. Rajan Ravichandran is the senior and lead author of this abstract, Director of Nephrology at MIOT Hospitals, and Chairman of Sapiens Health Foundation.
